Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. insulin secretion
Show results for
Products
Applications

Companies


Refine by

Insulin Secretion Articles & Analysis

9 news found

Ace Therapeutics Releases Diabetic Mouse Models for Preclinical Diabetes Research

Ace Therapeutics Releases Diabetic Mouse Models for Preclinical Diabetes Research

Diabetes mellitus is a chronic, systemic, metabolic disease caused by the long-term combination of genetic factors and environmental factors, characterized by increased plasma glucose levels, mainly due to insufficient insulin secretion or dysfunction in the body (insulin resistance). Diabetes can be categorized into three primary forms - type 1, ...

ByAce Therapeutics


Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

Creative Enzymes Unveils Semaglutide, a Promising Solution for Comprehensive Diabetes Management

Semaglutide's mechanism of action involves stimulating the production and secretion of insulin, while simultaneously suppressing the release of glucagon, a hormone that raises blood sugar levels. ...

ByCreative Enzymes


CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery   

CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery  

For instance, a study published in the Journal of Controlled Release explored the use of coated microneedles for the delivery of insulin. The results showed that this novel drug delivery system has achieved a sustained release of insulin, mimicking the physiological pattern of insulin secretion in healthy individuals. ...

ByCD Formulation


Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes

Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes

In contrast to T2D, which is primarily a chronic metabolic disease, in type 1 diabetes the insulin secreting cells of the pancreas are destroyed, which is deemed to be attributable to factors such as genetics and environmental triggers. ...

ByBayer AG


Peptides for Diabetes Research—a Special Offer of BOC Sciences

Peptides for Diabetes Research—a Special Offer of BOC Sciences

Its peptides for diabetes research are recently brought into focus due to the growing concerns on this problem According to data from the WHO, a large number of adults are having diabetes mellitus, a chronic metabolic disorder characterized by hyperglycemia. The absolute lack of insulin, due to destruction of the insulin producing pancreatic β-cells, is ...

ByBOC Sciences


First patient enrolled in Diamyd Medical`s Phase III trial Diagnode-3

First patient enrolled in Diamyd Medical`s Phase III trial Diagnode-3

” “Preserving some own insulin secretion is the best way to mitigate type 1 diabetes, prevent complications and provide a good quality of life," says Johnny Ludvigsson, Professor at Linköping University and Coordinating Iinvestigator for DIAGNODE-3. ...

ByDiamyd Medical AB


Patent for Cell Selection of Beta Cells to Treat and Potentially Cure Diabetes was Granted in Japan

Patent for Cell Selection of Beta Cells to Treat and Potentially Cure Diabetes was Granted in Japan

IsletRx comprises an expanded population of clinical grade pancreatic islet-like cluster (ILCs) cells, derived from human stem cells, that have the ability to secrete insulin when blood sugar is low and glucagon, a hormone secreted to prevent hypoglycemia, when blood sugar levels drop in response to varying sugar levels (glucose) in the blood. ...

ByKadimastem Ltd.


Top 5 Israeli innovations of the past decade

Top 5 Israeli innovations of the past decade

It can be inserted underneath the skin, without anesthesia and “reprograms” the natural pancreas to function correctly, by teaching it how to properly administer insulin. The pancreas, which is located in the abdomen, is a vital organ crucial to the digestive process. In diabetic patients, it doesn’t produce enough insulin, causing the amount of ...

ByBetalin Therapeutics Ltd.


Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Never mind better insulin shots or cell implants for diabetics: Betalin Therapeutics has a unique approach. ...

ByBetalin Therapeutics Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT